This old version of Proteopedia is provided for student assignments while the new version is undergoing repairs. Content and edits done in this old version of Proteopedia after March 1, 2026 will eventually be lost when it is retired in about June of 2026.
Apply for new accounts at the new Proteopedia. Your logins will work in both the old and new versions.
6ln1
From Proteopedia
(Difference between revisions)
m (Protected "6ln1" [edit=sysop:move=sysop]) |
|||
| Line 1: | Line 1: | ||
| - | '''Unreleased structure''' | ||
| - | + | ==A natural inhibitor of DYRK1A for treatment of diabetes mellitus== | |
| - | + | <StructureSection load='6ln1' size='340' side='right'caption='[[6ln1]]' scene=''> | |
| - | + | == Structural highlights == | |
| - | + | <table><tr><td colspan='2'>Full crystallographic information is available from [http://oca.weizmann.ac.il/oca-bin/ocashort?id=6LN1 OCA]. For a <b>guided tour on the structure components</b> use [https://proteopedia.org/fgij/fg.htm?mol=6LN1 FirstGlance]. <br> | |
| - | + | </td></tr><tr id='resources'><td class="sblockLbl"><b>Resources:</b></td><td class="sblockDat"><span class='plainlinks'>[https://proteopedia.org/fgij/fg.htm?mol=6ln1 FirstGlance], [http://oca.weizmann.ac.il/oca-bin/ocaids?id=6ln1 OCA], [https://pdbe.org/6ln1 PDBe], [https://www.rcsb.org/pdb/explore.do?structureId=6ln1 RCSB], [https://www.ebi.ac.uk/pdbsum/6ln1 PDBsum], [https://prosat.h-its.org/prosat/prosatexe?pdbcode=6ln1 ProSAT]</span></td></tr> | |
| - | [[Category: | + | </table> |
| + | __TOC__ | ||
| + | </StructureSection> | ||
| + | [[Category: Large Structures]] | ||
| + | [[Category: Chen JC]] | ||
| + | [[Category: Chen LX]] | ||
| + | [[Category: Li C]] | ||
| + | [[Category: Li H]] | ||
| + | [[Category: Song ZR]] | ||
| + | [[Category: Wang QQ]] | ||
| + | [[Category: Wu CR]] | ||
| + | [[Category: Yang KY]] | ||
| + | [[Category: Zhang CL]] | ||
| + | [[Category: Zhang QZ]] | ||
| + | [[Category: Zheng MZ]] | ||
| + | [[Category: Zhou YR]] | ||
Revision as of 05:26, 6 October 2021
A natural inhibitor of DYRK1A for treatment of diabetes mellitus
| |||||||||||
